Target intelligence / Profile preview

Myelin Basic Protein-Reactive T Cell (MBP-reactive T cell)

Target
MBP-reactive T cell
Molecular classification
T cell, Lymphocyte, CD4+ T cell, CD8+ T cell
01

Overview

Myelin basic protein (MBP)-reactive T cells are a subset of autoreactive T lymphocytes that specifically recognize epitopes derived from myelin basic protein, a key structural component of the myelin sheath in the central nervous system. These cells play a significant role in the pathogenesis of autoimmune demyelinating diseases, most notably multiple sclerosis (MS). These autoreactive T cells are activated, clonally expanded, and accumulate within the brain compartment. Both CD4+ helper and CD8+ cytotoxic MBP-reactive T cell subsets have been identified. Activation can occur through direct recognition of self-MBP peptides presented by MHC molecules on antigen-presenting cells, or through molecular mimicry from microbial peptides.

Other names
MBP-specific T cellMyelin basic protein-specific T lymphocyteAutoreactive T cell to MBP
02

Mechanism of action

T cell vaccination aims to induce regulatory networks that suppress or deplete circulating autoreactive populations. Other drugs (immunosuppressants, anti-inflammatories) have broader effects on the immune system.

03

Biological functions

Antigen recognitionCytokine secretionT cell activationCell-mediated cytotoxicityImmune response
04

Disease associations

Multiple sclerosisExperimental autoimmune encephalomyelitis (EAE)Autoimmune diseaseNeuroinflammationDemyelination
05

Safety considerations

ImmunosuppressionOff-target effects of immunotherapiesPotential for exacerbation of autoimmunity in some individualsRisk of infection
06

Interacting drugs

T cell vaccination (attenuated autologous MBP-reactive clones)

2 more in the full profile.

07

Biomarkers

Frequency of MBP-reactive T cells in peripheral bloodCytokine profile (IFN-gamma, TNF-alpha) upon MBP stimulationClonal expansion of MBP-reactive T cells in cerebrospinal fluidCD45RA-/CD45RO+ expression (memory phenotype)

Beyond the preview

Go deeper on Myelin Basic Protein-Reactive T Cell (MBP-reactive T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myelin Basic Protein-Reactive T Cell (MBP-reactive T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call